Professor Paul Workman OBE has been awarded the Enrst W. Bertner Memorial Award by The University of Texas MD Anderson Cancer Center, for his distinguished contributions to cancer research. The award, ...
People with localised, low-to-intermediate-risk prostate cancer could benefit from Stereotactic Body Radiation Therapy (SBRT), a highly targeted form of radiotherapy, which research suggests may be ...
The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to ...
New research has found that a rare form of triple-negative breast cancer has a generally favourable long-term prognosis and may not require the same treatment approach as more common triple-negative ...
PENELOPE B is a phase III international, multicentre, randomised, placebo-controlled, double-blind trial comparing the efficacy and safety of adding palbociclib to standard hormone therapy vs standard ...
Merenienla Yaden is a Research Administrator at the Institute of Cancer Research, contributing to the NHS Jewish BRCA Testing Programme within Professor Clare Turnbull’s team in the Division of ...
What is the study about? HER2-RADiCAL is investigating whether some people with HER2 positive breast cancer can safely receive less treatment after surgery. HER2 is a protein which can cause cancer to ...
Christine O’Connell set up the One More City fundraising campaign after she was diagnosed with breast cancer. She and her cycling teammates have raised more than £500,000 to support much-needed ...
Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...
Up to two in five advanced prostate cancer patients could be treated with a combination of two targeted drugs, according to new research. Findings by a team of scientists at The Institute of Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results